Market: NMS |
Currency: USD
Address: 300 Connell Drive
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
📈 CorMedix Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$14.57
-
Upside/Downside from Analyst Target:
100.43%
-
Broker Call:
14
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
<0%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
>500%
-
Upcoming Earnings Date:
2026-05-06
-
EPS Estimate:
0.33
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for CorMedix Inc.
| Date | Reported EPS |
|---|
| 2026-05-06 (estimated upcoming) | - |
| 2026-03-05 | 0.16 |
| 2025-11-12 | 1.41 |
| 2025-08-07 | 0.28 |
| 2025-05-06 | 0.3 |
| 2025-03-25 | 0.22 |
| 2024-10-30 | -0.05 |
| 2024-08-14 | -0.25 |
| 2024-05-09 | -0.25 |
| 2024-03-12 | -0.26 |
| 2023-11-14 | -0.17 |
| 2023-08-08 | -0.25 |
| 2023-05-15 | -0.24 |
| 2023-03-30 | -0.2 |
| 2022-11-10 | -0.17 |
| 2022-08-11 | -0.19 |
| 2022-05-12 | -0.18 |
| 2022-03-29 | -0.2 |
| 2021-11-09 | -0.22 |
| 2021-08-12 | -0.12 |
| 2021-05-13 | -0.2 |
| 2021-03-30 | -0.19 |
| 2020-11-05 | -0.22 |
| 2020-08-10 | -0.14 |
| 2020-05-11 | -0.21 |
📰 Related News & Research
🔍 View more Reports
